Gleason Group »

Vertex Pharmaceuticals Incorporated shares owned by Gleason Group

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Gleason Group from 13F filings

Historical chart of Gleason Group investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Gleason Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Gleason Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.9k 16 496.75

More positions owned by Gleason Group

Vanguard S&p 500 Etf idx (VOO)
Vanguard Total Stock Market ETF (VTI)
Vanguard Extended Market ETF (VXF)
Vanguard Star Fd Intl Stk Idxf (VXUS)
Vanguard Value ETF (VTV)
Vanguard Growth ETF (VUG)
Schwab Strategic Tr us lrg cap etf (SCHX)
Vanguard Mun Bd Fd Inc tax-exempt bd (VTEB)
Vanguard Wellington (VTES)
iShares S&P 1500 Index Fund (ITOT)
Vanguard Intmdte Tm Govt Bd ETF (VGIT)
Vanguard Lg Term Govt Bd ETF (VGLT)
Vanguard Emerging Markets ETF (VWO)
Schwab International Equity ETF (SCHF)
Vanguard High Dividend Yield ETF (VYM)

View all positions for Gleason Group

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Alliancebernstein
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas
Bank of America Corporation
Jennison Associates

View all funds holding Vertex Pharmaceuticals Incorporated